Royal Bank of Canada Lowers Avid Bioservices (NASDAQ:CDMO) P

Avid Bioservices (NASDAQ:CDMO – Free Report) had its target price lowered by Royal Bank of Canada from $17.00 to $15.00 in a research report sent to investors on Friday morning, Marketbeat.com reports. Royal Bank of Canada currently has an outperform rating on the biopharmaceutical company’s stock. Separately, Stephens decreased their target price on Avid Bioservices […]

Related Keywords

Kentucky , United States , Canada , Richarda Richieri , , Wells Fargo Company , Alberta Investment Management Corp , Securities Exchange Commission , Royal Bank , Nuveen Asset Management , Legato Capital Management , Avid Bioservices Inc , Avid Bioservices , Free Report , Bioservices Stock Down , Get Free Report , Stewart Green , Exchange Commission , Investment Management Corp , Retirement System , Capital Management , Asset Management , Wells Fargo , Avid Bioservices Daily , Nasdaq Cdmo , Cdmo , Medical , Lower Price Target , Royal Bank Of Canada ,